Plasma lipoprotein (a), homocysteine, and other cardiovascular disease (CVD) risk factors in Nigerians with CVD

Applied Physiology, Nutrition and Metabolism

Volumn 33, Issue 2, 2008, Pages 282-289

  Ebesunun, M O ^a   Agbedana, E O ^b   Taylor, G O L ^b   Oladapo, O O ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

CVD; Homocysteine; Lipoprotein (a); WHR

Indexed keywords

HOMOCYSTEINE; LIPOPROTEIN A;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD; BLOOD PRESSURE; BODY COMPOSITION; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; NIGERIA; PHOTOMETRY; PHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; SKELETAL MUSCLE; SKINFOLD THICKNESS; SOCIOECONOMICS; WAIST HIP RATIO;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; BLOOD PRESSURE; BODY COMPOSITION; CARDIOVASCULAR DISEASES; FEMALE; HOMOCYSTEINE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEPHELOMETRY AND TURBIDIMETRY; NIGERIA; RISK FACTORS; SEX FACTORS; SKINFOLD THICKNESS; SOCIOECONOMIC FACTORS; WAIST-HIP RATIO;

EID: 41649099877     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H07-186     Document Type: Article

References (38)

1. Akinkugbe, O.O. 1988. Epidemiology of hypertension and stroke in Africa. In Hypertension and stroke control in the community Geneva. Vol. 6. Edited by S. Hateno. WHO, Geneva, Switzerland. pp. 2-4.
2. Alexandre, L., Hester, V., Ian, K., O'Nell, T.N., Sheila, A.B., Runswick, K., et al. 1999. Apoliprotein E and methylenetetrahydrofolate reductase genetic polymorphisms in relation to other risk factors for cardiovascular disease in UK Caucasians and Black South Africans. Arteriosclerosis, 145: 125-135. doi:10.1016/S0021-9150(99)00022-2.
3. Alfthan, G., Pekkanen, J., and Jauhiainen, M. 1997. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in prospective Finnish population based study. Atherosclerosis, 106: 9-19. doi:10.1016/0021-9150(94)90078-7.
4. Amouzou, E.K., Chabbi, N.W., Adejalla, C.E., Rodriguez, R.M., Feillet, G.F., Ambaliou, C.V., et al. 2004. High prevalence of hyperhomocysteinemia related to folate deficiency and the 677C-T mutation of the gene encoding methylenetetrahydrofolate reductase in coastal West African. Am. J. Clin. Nutr. 79: 619-624.
5. Angelin, B. 1997. Therapy for lowering lipoprotein(a) levels. Curr. Opin. Lipidol. 8: 337-341. doi:10.1097/00041433-199712000-00003.
6. Antonia, T., Charalambos, G., Areti, L., Vassiliki, B., Andronniki, N., and Dimitrios, T. 2001. Physical activity and energy intake selectively predict the waist-to-hip ratio in men: but not in women. Am. J. Clin. Nutr. 74: 574-576.
7. Arnesen, E., Refsum, H., Bonaa, K.H., Ueland, P.M., Forde, O.H., and Nordrehaug, J.E. 1995. Serum total homocysteine and coronary heart disease. Int. J. Epidemol. 24: 704-709.
8. Beaglehole, R. 1992. Cardiovascular disease in developing countries. Br. Med. J. 305: 1171-1172.
9. Canoy, D., Luben, R., Welch, A., Bingham, S., Wareham, N., Day, N., et al. 2004. Fat of BMI and blood pressure in 2209 in Norfolk cohort of the European Prospective Investigation into cancer and nutrition (EPIC-Norfolk) study. J. Hypertens. 22: 2067-2074. doi:10.1097/00004872-200411000-00007.
10. Cantin, B., Gannon, F., and Moorjam, S. 1998. Is lipoprotein (a) an independent risk factors for ischaemic in? The Quebec Cardiovascular Study. J. Am. Coll. Cardiol. 31: 519-525. doi:10.1016/S0735-1097(97)00528-7.
11. Cole, A.H., and Udekwe, I.O. 1989. Body composition, energy, protein and iron intake of Nigerian female nursing students. Die. Nahrung, 33: 703-708.
12. Craig, W.Y., Neveux, L.M., Pakomaki, G.E., Cleverland, M.M., and Haow, J.E. 1998. Lipoprotein(a) as a risk factor for ischaemic heart disease: metanalysis of prospective studies. Clin. Chem. 44: 2301-2306.
13. Edwards, D.A. 1951. Differences in the distribution of subcutaneous fat with sex and maturity. Clin. Sci. 10: 305-315.
14. Evans, RW.., Shaten, B.J., Hampel, J.D., Cutler, J.A., and Kuller, L.H. 1997. Homocysteine and risk of cardiovascular disease in Multiple Risk Factor Intervention Trial. Arterioscler. Thromb. Vasc. Biol. 17: 1947-1953.
15. Graham, I.M., Daly, M., and Refsum, H. 1997. Plasma homocysteine as a risk factor for vascular disease. JAMA, 269: 483-487.
16. Hamid, M., Nadar, R., Farhadv, R., and Mahbanou, G. 2004. Can we predict cardiovascular risk factors in women? Cell. Mol. Biol. Lett. 9: 1-6.
17. Jonasson, T.F., Hedner, T., Hultberg, B., and Ohlin, H. 2003. Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease. Eur. J. Clin. Invest. 33: 543-549.
18. Kaufman, J.S., Owoaje, E., James, S.A., Rotimi, C.N., and Copper, R.S. 1996. Determinants of hypertension in West Africa contribution of anthropometric and dietary factors to urban-rural and socio-economic gradients. Am. J. Epidemiol. 143: 1203-1218.
19. Klausen, I.C., Sjol, A., Hansen, P.S., Gerdes, L.U., Moller, L., Lemming, L., et al. 1997. Apoprotein(a) isoforms and coronary heart disease in men a nested case control study. Atherosclerosis, 132: 77-84. doi:10.1016/S0021-9150(97)00071-3.
20. Kronenberg, F., Steinmetz, A., Kostner, G.M., and Dieplinge, H. 1996. Lipoprotein (a) in health and disease. Crit. Rev. Clin. Lab. Sci. 33: 495-543. doi:10.3109/10408369609080056.
21. Lapidus, L., Bengston, B., Pennert, K., Itybo, E., and Sjostron, L. 1994. Distribution of adipose tissue and risk of cardiovascular disease and death: 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Med. J. 284: 1257-1261.
22. Lip, G.Y.H., and Jones, A.F. 1995. Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis. Q. J. Med. 88: 529-539.
23. Marcovina, S.M., Albers, J.J., Wijsman, E., Zhang, Z., Chapman, N.H., and Kennedy, H. 1996. Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J. Lipid Res. 37: 2569-2585.
24. Moliterno, D.J., Jokinen, E.V., and Miserez, A.R. 1995. No association between lipoprotein(a) concentration and the presence or absence of coronary atherosclerosis in African- Americans. Arterioscler. Thromb. Vasc. Biol. 15: 850-855.
25. Nygard, O., Refsum, H., Ueland, F.M., and Voiliset, S.E. 1998. Major lifestyle determinants of plasma homocysteine distribution - the Hordland homocysteine study. Am. J. Clin. Nutr. 67: 263-270.
26. Phillips, M.L., Lembert, A.V., Schunaker, V.N., Lawn, R.L., Shire, S.J., and Zioncheck, T.F. 1993. Enhanced turbdimetric quantitative determination of plasma lipoprotein (a). Biochemistry, 32: 3722. doi:10.1021/bi00065a026.
27. Rowland, M.L. 1989. A nomogram for computing body mass index. Dietetic Curr. 16: 5-12.
28. Sandholzer, C., Boewinkle, E., Saha, N., Tong, M.C., and Litermann, G. 1992. Apoliprotein phenotypes, Lp(a) concentrations and plasma lipid levels in relation to coronary artery diseases in a Chinese population: evidence for the role of apolipoprotein (a) genes in coronary artery disease. J. Clin. Invest. 89: 1039-1045.
29. Scanu, A.M. 1998. Proteolytic modification of lipoprotein(a): potential relevance to its postulated atherothrombogenic role. J. Investig. Med. 46: 359-363.
30. Sechi, L.A., Zingaro, L., and De Carli, S. 1998. Increase serum lipoprotein( a) in patients early renal failure. Ann. Intern. Med. 129: 457-461.
31. Stampler, M.J., Malinow, M.R., Willettw, C., and Newcomer, L.A. 1997. Prospective study of plasma homocysteine and risk of myocardial infarction in US Physicians. J. Med. Assoc. 268: 887-891.
32. Taylor, G.O., and Agbedana, E.O. 1983. A comparative study of plasma high density lipoprotein cholesterol in two groups of Nigerians of different socio- economic groups. Afr. J. Med. Med. Sci. 12: 23-28.
33. Ulbricht, T.L., and Southgate, D.A. 1991. Coronary heart disease: seven dietary factors. Lancet, 338: 985-992. doi:10.1016/0140-6736(91)91846-M.
34. Unwin, N., and Albert, G. 2000. Primary health-care intervention for non-communicable diseases. Afr. Health, 22: 12-14.
35. Wald, N.J., Watt, H., Law, M.R., Wier, D.G., Mcpartlin, J., and Scott, J.M. 1998. Homocysteine and ischeamic heart disease results of prospective study with implication regarding prevention. Arch. Intern. Med. 158: 862-867. doi:10.1001/archinte.158.8.862.
36. WHO Expert Committee. 1982. Prevention of coronary heart disease. WHO technical report aeries. Vol. 678. WHO, Geneva, Switzerland.
37. Yuan, J.M., Ross, R.K., Gao, Y.T., and Yu, M. 1998. Body weight and mortality a prospective evaluation in a cohort of middle-aged men in Shanghai, China. Int. J. Epidemiol. 27: 824-832. doi:10.1093/ije/27.5.824.
38. Ziad, A.M. 2000. Importance of homocysteine, lipoprotein(a) and non classical cardiovascular risk factors (fibrinogen and advance glycation end-products for athreogenesis in uraemic patients). Nephrol. Dial. Transplant. 15(l5): 81-91. doi:10.1093/ndt/15.suppl_5.81.